New Jersey Health Foundation (NJHF) has awarded more than $1.5 million in seed funding to Rowan University researchers this ...

It focuses on two key biomarkers: a repetitive RNA sequence that accumulates in Parkinson's patients, and mitochondrial RNA -- which declines as the disease progresses, said the Hebrew University of ...

A new study identifies a blood-based biomarker that detects pre-symptomatic Parkinson’s disease by measuring the ratio of specific nuclear and mitochondrial transfer RNA fragments. The test ...

A new study identifies a blood-based biomarker that detects pre-symptomatic Parkinson’s disease by measuring the ratio of ...

Jerusalem: Israeli researchers have developed a new RNA-based blood test for detecting Parkinson's disease long before symptoms emerge. Parkinson's is often diagnosed only after significant brain ...

It focuses on two key biomarkers: a repetitive RNA sequence that accumulates in Parkinson’s patients, and mitochondrial RNA, which decreases as the disease progresses. By analyzing the ratio between ...

It focuses on two key biomarkers: a repetitive RNA sequence that accumulates in Parkinson's patients, and mitochondrial RNA, which declines as the disease progresses. By measuring the ratio between ...

focusing on a repetitive RNA sequence that builds up in Parkinson’s patients and a simultaneous drop in mitochondrial RNA. By analyzing the ratio between these biomarkers, the test provides a ...

focusing on a repetitive RNA sequence that accumulates in Parkinson's patients and a parallel decline in mitochondrial RNA, which deteriorates as the disease progresses. By measuring the ratio ...

focusing on a repetitive RNA sequence that accumulates in Parkinson’s patients and a parallel decline in mitochondrial RNA, which deteriorates as the disease progresses. By measuring the ratio ...